Cortisone Injection Not Working: What to Do When the Shot Stops Helping

When cortisone injections no longer provide adequate relief — or the window keeps getting shorter — it's time to understand why, and what the evidence-based alternatives actually are.

At a Glance

When Cortisone Stops Working: Understanding What's Happening

You've had the cortisone injection — possibly more than once. The first one worked well. The second was shorter. Now the shot isn't doing much, or it wears off faster than it used to. The joint pain that brought you to your doctor in the first place is still there, and the tool that managed it is becoming less effective.

This is a frustrating but recognisable pattern. It doesn't mean nothing can be done. It means the management approach needs to evolve beyond what a cortisone injection can provide.

Understanding why injections stop working — and what options remain — is the most useful thing you can do at this stage.

Why a Cortisone Injection May Not Be Working

The injection may not have been placed precisely in the target tissue

Accuracy of injection placement significantly influences effectiveness. Research comparing ultrasound-guided injections to landmark-guided injections has found that guided placement is associated with better pain outcomes. If previous injections provided limited relief, ultrasound-guided delivery is worth discussing with your doctor for any future injections.

The underlying condition may not be primarily inflammation-driven

Cortisone is an anti-inflammatory agent. If the primary driver of joint pain is mechanical — bone-on-bone wear in advanced osteoarthritis, structural instability, or biomechanical factors — an anti-inflammatory injection addresses only a component of the problem. Some patients find that cortisone provides no meaningful relief because their pain is not primarily inflammatory in nature.

The underlying condition may have progressed

If cortisone injections were effective 12–18 months ago but are now providing shorter or less complete relief, this may reflect progression of the underlying joint condition. As osteoarthritis advances, the structural changes in cartilage and bone become more significant drivers of pain alongside the inflammatory component — and cortisone addresses only the latter.

The joint environment may have changed in ways that limit cortisone's effect

Repeated corticosteroid exposure also raises tissue-safety questions, which is why clinicians usually avoid relying on injections as the only long-term strategy. This is one of several reasons doctors typically pair injections with a broader management plan rather than repeating them indefinitely.

Still in Pain: The Cortisone Flare and Post-Injection Pain Patterns

Before concluding that a cortisone injection has not worked, it is important to confirm which post-injection pain pattern you are experiencing.

Cortisone flare — pain that increases 24–48 hours after the injection, then resolves within 72 hours — is not an indication that the injection has failed. It is a short-term crystalline irritation response. If the pain after this period reduces significantly, the injection has likely worked despite the initial flare.

No improvement after 7–10 days — if there has been no reduction in pain or swelling after 7–10 days, the injection may not have reached the intended target, or the condition may not be responsive to corticosteroid treatment. This is worth discussing with your doctor.

Pain returning within 2–3 weeks — if improvement occurred but disappeared unusually quickly, this suggests the underlying condition is driving a high inflammatory load that the injection suppressed only briefly. The injection has worked mechanistically, but the underlying condition is generating inflammation faster than the corticosteroid can suppress it at this dose.

The Root Cause Question: What's Actually Driving the Pain?

When injections stop working or provide diminishing relief, it is an important moment to return to the root cause question — what is actually generating the pain signal, and is that condition being addressed?

For osteoarthritis — cartilage thinning, bone remodelling, and altered joint mechanics are the structural drivers. Cortisone manages the inflammatory consequence of these changes but does not slow or reverse them. The evidence-based approaches that may influence the trajectory include: structured physiotherapy to strengthen supporting muscles, weight management to reduce mechanical load, and joint support during the between-injection windows.

For inflammatory arthritis (rheumatoid, psoriatic, reactive) — the underlying immune dysregulation is the root cause. Cortisone suppresses the inflammatory response locally and temporarily, but disease-modifying medications (DMARDs, biologics) address the systemic immune activity that local injections cannot. If you have inflammatory arthritis and cortisone is no longer providing adequate relief, this is an important conversation to have with your rheumatologist about your disease-modifying medication regimen.

For tendon conditions — tendinopathy (the more accurate term for many chronic tendon conditions, replacing "tendonitis" in much of the current literature) is often not primarily inflammatory, particularly in chronic cases. Cortisone may provide temporary relief but the evidence for its long-term effectiveness in tendinopathy is more limited than for joint conditions. Structured tendon loading exercises — specifically eccentric strengthening — are among the most evidence-supported approaches for tendinopathy management.

Knowing which category your pain falls into significantly changes what the next step should be.

Evidence-Based Alternatives When Cortisone Is No Longer Adequate

Physical therapy — the most evidence-consistent option across all joint conditions

Structured physiotherapy targeting the specific joint and its surrounding muscle groups is the intervention with the most consistent evidence across knee, hip, shoulder, and lumbar pain. It addresses the mechanical factors that cortisone cannot — muscle weakness, movement patterns, load distribution — and its effects improve over time rather than diminishing.

Structured exercise is consistently recommended as a core non-surgical strategy for osteoarthritis because it addresses strength, load distribution, movement tolerance, and function — the factors cortisone does not change. A 2025 review in BMJ found that among exercise types studied for knee osteoarthritis, aerobic exercise ranked among the most beneficial for improving pain, function, gait, and quality of life — reinforcing structured exercise as a primary rather than secondary intervention in current clinical guidance.

Hyaluronic acid injections (viscosupplementation)

Hyaluronic acid (HA) injections work through a fundamentally different mechanism than cortisone. Rather than suppressing inflammation, they provide lubrication and cushioning to the joint. The evidence for HA is mixed — more consistent for knee osteoarthritis than for other joints — but for some patients, HA provides longer-lasting relief than cortisone with fewer concerns about cumulative tissue effects. It is typically considered when cortisone is no longer adequate and as an alternative to surgical management.

Platelet-rich plasma (PRP)

PRP injections use components of the patient's own blood to deliver growth factors to the affected tissue. The evidence base is growing but not yet definitive — guidelines vary on recommendation. For knee osteoarthritis specifically, some studies have shown comparable or superior outcomes to cortisone at 6–12 months. For tendinopathy, PRP evidence varies considerably by tendon and diagnosis — for some conditions, such as lateral elbow tendinopathy, current evidence suggests limited clinically meaningful benefit. Some clinicians consider PRP when repeated cortisone is no longer appropriate, but it should be discussed as a specialist-led option for your specific condition rather than treated as a guaranteed upgrade.

Structured weight management

For weight-bearing joints — knees, hips, ankles — each kilogram of body weight removed reduces the mechanical load on the joint significantly. Even modest weight reduction has been associated with meaningful reductions in knee osteoarthritis pain in multiple clinical trials.

Surgical consultation

When cortisone injections and conservative management have been appropriately trialled and no longer provide adequate function, surgical options — joint replacement for advanced osteoarthritis, arthroscopy for specific mechanical problems — may be appropriate. The important point is that surgical consultation does not mean immediate surgery. It means an informed conversation about what surgery involves, what the realistic outcomes are, and whether the timing is appropriate. (See: The Window Before Knee Replacement Surgery Most People Miss)

Where Targeted Topical Joint Support Fits

Cortisone manages the acute inflammatory environment. What it does not provide is ongoing support for the cartilage and joint environment between injections, or a long-term approach to joint maintenance once injections are no longer providing adequate relief.

This is a gap that targeted transdermal joint support is designed to address — not as a replacement for medical management, but as part of a broader approach alongside physiotherapy, diet, load management, and medical care. This gives targeted topical support a distinct role within that wider routine.

URAH Joint Health Omega-3 delivers micellar glucosamine and Omega-3 fatty acids in a transdermal formulation applied directly over the joint area — providing a localised joint-support step at the application site. Peer-reviewed research published in the Hong Kong Physiotherapy Journal (Onigbinde et al., 2018) reported improvements in pain, stiffness, and functional outcomes following a transdermal glucosamine intervention over 12 weeks. For active individuals with high-demand joint loads, URAH Sporting Cream MSM may also be relevant.

Neither product positions itself as a cortisone replacement or a treatment for arthritis. They are adjunctive tools — targeted, topical, and designed for consistent joint support between medical interventions — for people managing long-term joint conditions who need more than what cortisone alone provides.

A Note on Timing: Don't Wait Until Pain Reaches Crisis Level

The most common pattern is this: cortisone injection → pain reduces → relief fades → pain returns to pre-injection level → repeat injection. The time between injections becomes the period of pain, rather than the period of active management.

Reversing this pattern — using the injection window actively and building the between-injection support structure — is more effective than relying on the injection alone to carry the management load.

The physio, the dietary changes, and the targeted joint support routine are more useful when they start during the cortisone window (when pain is low and movement is accessible) than when they are introduced as a response to pain returning.

FAQ

Why is my cortisone injection not working anymore?

Several factors may explain diminishing effectiveness: the underlying condition may have progressed, meaning structural changes now drive more of the pain alongside inflammation; the joint environment may have changed in ways that limit corticosteroid responsiveness; or the injection placement may not have reached the intended tissue precisely. Discussing these possibilities with your doctor helps determine whether to modify the injection approach, add complementary management, or transition to a different treatment strategy.

What are the alternatives to cortisone injections for joint pain?

Evidence-based alternatives include structured physiotherapy, hyaluronic acid injections (for knee osteoarthritis specifically), platelet-rich plasma (PRP) injections, weight management for weight-bearing joints, anti-inflammatory dietary changes, and targeted topical joint support. The most appropriate option depends on which joint is affected, the underlying condition, and how far it has progressed. (See: Anti-Inflammatory Diet for Joint Pain)

Is it safe to have cortisone injections indefinitely?

Many clinicians limit cortisone injections to around 3–4 per joint per year, depending on the joint, diagnosis, dose, and individual risk factors. Repeated high-dose corticosteroid exposure has been associated with cumulative tissue effects in some research. If you are reaching this limit without adequate pain control, this is a signal to discuss longer-term management alternatives with your doctor.

Can joint support supplements replace cortisone injections?

No. Glucosamine and Omega-3 products are not replacements for cortisone injections and should not be presented as such. They serve a different function: supporting the joint environment over time, addressing cartilage and synovial health in ways cortisone does not. For many people, they are most useful as an adjunctive approach alongside appropriate medical management.

When should I consider surgery if cortisone isn't working?

Surgical consultation is worth considering when: multiple cortisone injections have provided diminishing returns, conservative management including physiotherapy has been appropriately trialled, and joint pain is significantly affecting quality of life and function. Consultation does not mean a commitment to surgery — it means an informed conversation about options, timing, and what to realistically expect from surgical intervention.

Further Reading

In this series:

• Joint Pain After a Cortisone Injection: Why Pain Comes Back — the biology behind recurrence

• How Long Does a Cortisone Injection Last? — what to expect week by week

Related URAH blogs:

• The Window Before Knee Replacement Surgery Most People Miss

• Why Glucosamine Pills Don't Work for Joint Pain

• Rheumatoid Arthritis: Natural Pain Relief Between Flares

• Does Stress Cause Joint Pain?

References

1. Bannuru RR, et al. Comparative effectiveness of pharmacological interventions for knee osteoarthritis. Annals of Internal Medicine, 2015.

2. McAlindon TE, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain. JAMA, 2017.

3. Comparative efficacy and safety of exercise modalities for knee osteoarthritis: a systematic review and network meta-analysis. BMJ, 2025.

4. Jawanda H, et al. Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Arthroscopy, 2024.

5. Onigbinde AT, et al. Transdermal glucosamine for musculoskeletal conditions. Hong Kong Physiotherapy Journal, 2018.

6. Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline. Journal of the American Academy of Orthopaedic Surgeons, 2013.